- Home
- RVPH vs SRFM Comparison
RVPH vs SRFM Comparison
Compare RVPH & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SRFM
- Stock Information
- Founded
- RVPH 2006
- SRFM 2011
- Country
- RVPH United States
- SRFM United States
- Employees
- RVPH N/A
- SRFM N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- RVPH Health Care
- SRFM Consumer Discretionary
- Exchange
- RVPH Nasdaq
- SRFM Nasdaq
- Market Cap
- RVPH 37.1M
- SRFM 15.0M
- IPO Year
- RVPH N/A
- SRFM 2023
- Fundamental
- Price
- RVPH $1.19
- SRFM $1.90
- Analyst Decision
- RVPH Strong Buy
- SRFM Hold
- Analyst Count
- RVPH 5
- SRFM 2
- Target Price
- RVPH $14.50
- SRFM $2.50
- AVG Volume (30 Days)
- RVPH 285.5K
- SRFM 2.2M
- Earning Date
- RVPH 11-12-2024
- SRFM 11-12-2024
- Dividend Yield
- RVPH N/A
- SRFM N/A
- EPS Growth
- RVPH N/A
- SRFM N/A
- EPS
- RVPH N/A
- SRFM N/A
- Revenue
- RVPH N/A
- SRFM $111,793,000.00
- Revenue This Year
- RVPH N/A
- SRFM $104.61
- Revenue Next Year
- RVPH N/A
- SRFM $53.30
- P/E Ratio
- RVPH N/A
- SRFM N/A
- Revenue Growth
- RVPH N/A
- SRFM 392.91
- 52 Week Low
- RVPH $0.60
- SRFM $0.90
- 52 Week High
- RVPH $6.30
- SRFM $11.83
- Technical
- Relative Strength Index (RSI)
- RVPH 47.42
- SRFM 50.42
- Support Level
- RVPH $1.10
- SRFM $1.65
- Resistance Level
- RVPH $1.22
- SRFM $2.19
- Average True Range (ATR)
- RVPH 0.13
- SRFM 0.24
- MACD
- RVPH -0.02
- SRFM -0.04
- Stochastic Oscillator
- RVPH 22.68
- SRFM 16.15
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.